| Name | Title | Contact Details |
|---|
Patient First is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Pioneer Medical Group is a leader in the Hospitalist movement, providing the highest level of Hospital Medicine and Post Transition Care to Florida Hospitals in the West and Central Florida Region.
CeloNova BioSciences, Inc. is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Holy Redeemer Health System is committed to our mission to care, comfort and heal, and to providing excellent healthcare services to our community.